Clinical trial

Phosphodiesterase-5-inhibitors for Right Heart Failure After Left Ventricular Assist Device Implantation

NCT04117659

Study summary

ClinicalTrials.gov

Phosphodiesterase-5-inhibitors for Right Heart Failure After Left Ventricular Assist Device Implantation

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention withdrawal of oral medication (phosphodiesterase-5 inhibitor) in pretreated patients Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-10-15

PhaseNA

Conditions

Phosphodiesterase Inhibitor Adverse Reactionunresolved

Right-Sided Heart Failureunresolved

Interventions

withdrawal of oral medication (phosphodiesterase-5 inhibitor) in pretreated patientsOTHER

Sponsors & collaborators

University Hospital, Essenlead sponsor

Mapped research locations

EssenNorth Rhine-Westphalia, Germany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04117659 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.